These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 16644340)

  • 1. Increased cardiovascular risk associated with diabetes in Dallas County.
    Das SR; Vaeth PA; Stanek HG; de Lemos JA; Dobbins RL; McGuire DK
    Am Heart J; 2006 May; 151(5):1087-93. PubMed ID: 16644340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing recurrent events long term after coronary artery bypass graft: suboptimal use of medications in a population study.
    Bradshaw PJ; Jamrozik K; Gilfillan I; Thompson PL
    Am Heart J; 2004 Jun; 147(6):1047-53. PubMed ID: 15199354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of diabetes mellitus and its complications in a population-based sample in Al Ain, United Arab Emirates.
    Saadi H; Carruthers SG; Nagelkerke N; Al-Maskari F; Afandi B; Reed R; Lukic M; Nicholls MG; Kazam E; Algawi K; Al-Kaabi J; Leduc C; Sabri S; El-Sadig M; Elkhumaidi S; Agarwal M; Benedict S
    Diabetes Res Clin Pract; 2007 Dec; 78(3):369-77. PubMed ID: 17532085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease: a retrospective chart review involving up to 8 years of follow-up.
    Nichols GA; Koro CE; Chan W; Bowlin SJ; Sprecher DL
    Clin Ther; 2006 Feb; 28(2):243-50. PubMed ID: 16678645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elderly patients undergoing major vascular surgery: risk factors and medication associated with risk reduction.
    Feringa HH; Bax JJ; Karagiannis SE; Noordzij P; van Domburg R; Klein J; Poldermans D
    Arch Gerontol Geriatr; 2009; 48(1):116-20. PubMed ID: 18177954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Barzilay JI; Davis BR; Cutler JA; Pressel SL; Whelton PK; Basile J; Margolis KL; Ong ST; Sadler LS; Summerson J;
    Arch Intern Med; 2006 Nov; 166(20):2191-201. PubMed ID: 17101936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study).
    Reiner Z; Mihatov S; Milicić D; Bergovec M; Planinc D;
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):646-54. PubMed ID: 16874158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of mortality rates in statin users versus nonstatin users in a United States veteran population.
    Mehta JL; Bursac Z; Hauer-Jensen M; Fort C; Fink LM
    Am J Cardiol; 2006 Oct; 98(7):923-8. PubMed ID: 16996875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular risk factor management is poorer in diabetic patients with undiagnosed peripheral arterial disease than in those with known coronary heart disease or cerebrovascular disease. Results of a nationwide study in tertiary diabetes centres.
    González-Clemente JM; Piniés JA; Calle-Pascual A; Saavedra A; Sánchez C; Bellido D; Martín-Folgueras T; Moraga I; Recasens A; Girbés J; Sánchez-Zamorano MA; Mauricio D;
    Diabet Med; 2008 Apr; 25(4):427-34. PubMed ID: 18341592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of rosuvastatin use on costs and outcomes in patients at high risk for cardiovascular disease in US managed care and medicare populations: A data analysis.
    Huse DM; Song X; Ozminkowski RJ; Maguire J; Williams SA; Borok GM; McDonough K
    Clin Ther; 2006 Sep; 28(9):1425-42. PubMed ID: 17062315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the uses of aspirin, statins and ACEIs/ARBs in a diabetes outpatient population in southern Thailand.
    Pongwecharak J; Maila-ead C; Sakulthap J; Sripanitkulchai N
    J Eval Clin Pract; 2007 Apr; 13(2):221-6. PubMed ID: 17378868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating the diabetic patient: appropriate care for glycemic control and cardiovascular disease risk factors.
    Zarich SW
    Rev Cardiovasc Med; 2003; 4 Suppl 6():S19-28. PubMed ID: 14668700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of different markers of socioeconomic status with cardiovascular disease and diabetes risk factors in the Diabetes, Heart and Health Survey.
    Metcalf PA; Scragg RR; Schaaf D; Dyall L; Black PN; Jackson RT
    N Z Med J; 2008 Feb; 121(1269):45-56. PubMed ID: 18278081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients.
    Nichols GA; Koro CE
    Clin Ther; 2007 Aug; 29(8):1761-70. PubMed ID: 17919557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart.
    Anselmino M; Malmberg K; Ohrvik J; Rydén L;
    Eur J Cardiovasc Prev Rehabil; 2008 Apr; 15(2):216-23. PubMed ID: 18391651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discordance between physicians' estimation of patient cardiovascular risk and use of evidence-based medical therapy.
    Tsang JL; Mendelsohn A; Tan MK; Hackam DG; Leiter LA; Fitchett D; Lin PJ; Grima E; Langer A; Goodman SG;
    Am J Cardiol; 2008 Nov; 102(9):1142-5. PubMed ID: 18940280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is prestroke use of angiotensin-converting enzyme inhibitors associated with better outcome?
    Chitravas N; Dewey HM; Nicol MB; Harding DL; Pearce DC; Thrift AG
    Neurology; 2007 May; 68(20):1687-93. PubMed ID: 17502550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
    Fiuza M; Cortez-Dias N; Martins S; Belo A;
    Rev Port Cardiol; 2008 Dec; 27(12):1495-529. PubMed ID: 19280993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of undiagnosed Type-2-diabetes mellitus and impaired fasting glucose in German primary care: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS).
    Hauner H; Hanisch J; Bramlage P; Steinhagen-Thiessen E; Schunkert H; Jöckel KH; Wasem J; Moebus S
    Exp Clin Endocrinol Diabetes; 2008 Jan; 116(1):18-25. PubMed ID: 17926235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease.
    Mancini GB; Etminan M; Zhang B; Levesque LE; FitzGerald JM; Brophy JM
    J Am Coll Cardiol; 2006 Jun; 47(12):2554-60. PubMed ID: 16781387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.